Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential effects and mechanisms of breast inflammatory lesions on the occurrence and development of breast cancer. | Front Oncol | 2022 | 35992864 | PubTator, text mining | PubMed |
| Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms. | Curr Hematol Malig Rep | 2022 | 35986863 | PubTator, text mining | PubMed |
| 18F-FDG Micro PET/CT imaging to evaluate the effect of BRCA1 knockdown on MDA-MB231 breast cancer cell radiosensitivity. | Transl Oncol | 2022 | 35985202 | PubTator, text mining | PubMed |
| Case Report: A rare case of familial lung cancer requiring pneumonectomy in three male siblings. | Front Oncol | 2022 | 35982978 | PubTator, text mining | PubMed |
| Impact of homologous recombination deficiency biomarkers on outcomes in patients with early breast cancer: a systematic review protocol. | BMJ Open | 2022 | 35981778 | PubTator, text mining | PubMed |
| Association between XRCC3 rs861539 Polymorphism and the Risk of Ovarian Cancer: Meta-Analysis and Trial Sequential Analysis. | Biomed Res Int | 2022 | 35978646 | PubTator, text mining | PubMed |
| Chromosomal instability in adult-type diffuse gliomas. | Acta Neuropathol Commun | 2022 | 35978439 | PubTator, text mining | PubMed |
| Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial. | J Immunother Cancer | 2022 | 35977756 | PubTator, text mining | PubMed |
| GeneHome - a Novel Model to Deliver Care to Individuals with Genetic Predisposition to Cancer. | Cancer Control | 2022 | 35976772 | PubTator, text mining | PubMed |
| Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients. | Genome Med | 2022 | 35971132 | PubTator, text mining | PubMed |
| Role of Olaparib in the Management of Metastatic Castration-Resistant Prostate Cancer: A Japanese Clinician's Perspective. | Cancer Manag Res | 2022 | 35967752 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis. | Neoplasia | 2022 | 35964518 | PubTator, text mining | PubMed |
| Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): Higher-Than-Expected Prevalence of Recurrent Germline Pathogenic Variants. | Front Oncol | 2022 | 35957908 | PubTator, text mining | PubMed |
| PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them. | Int J Mol Sci | 2022 | 35955544 | PubTator, text mining | PubMed |
| Proteomic Analysis of Prostate Cancer FFPE Samples Reveals Markers of Disease Progression and Aggressiveness. | Cancers (Basel) | 2022 | 35954429 | PubTator, text mining | PubMed |
| The HPV Induced Cancer Resource (THInCR): a Suite of Tools for Investigating HPV-Dependent Human Carcinogenesis. | mSphere | 2022 | 35950764 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| RNA binding protein-based risk score model for prognosis prediction of patients with hepatocellular carcinoma. | Chin Med J (Engl) | 2022 | 35940897 | PubTator, text mining | PubMed |
| Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. | Front Oncol | 2022 | 35924163 | PubTator, text mining | PubMed |
| Heterogeneity of Organization of Subcompartments in DSB Repair Foci. | Front Genet | 2022 | 35923694 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=49